Adnavance Technologies Inc. Appoints Anthony P. Bihl III to its Board of Directors
2/28/2008 8:48:48 AM
VANCOUVER, British Columbia & SAN DIEGO--(BUSINESS WIRE)--Adnavance Technologies Inc., a developer of direct detection molecular diagnostic tests for medical applications, announced today that the company appointed Anthony P. Bihl III to its Board of Directors. Mr. Bihl served as CEO of Siemens Medical Solutions Diagnostics until his retirement in November 2007. He also served as president of Bayer Healthcare’s Diagnostic Division, which was acquired by Siemens in December 2006 for $5.4 billion. Mr. Bihl has more than 25 years in executive level management in healthcare that spans medical instrumentation (Sterling Diagnostic Imaging), manufacturing (E.I. Dupont) and medical diagnostics (Bayer & Siemens).